£32,557 - £35,888 per annum: Animal and Plant Health Agency: At the Animal and Plant Health Agency (APHA), we safeguard animal and plant health for the benefit of people, the environment and... Weybridge, Surrey

Dependent on experience: Etcembly: We are now looking for a Bioinformatics Analyst who will work on clinical data derived from Immune Oncology trials as part of our growing team. Oxford, Oxfordshire (GB)

Notice NOT-NS-21-074 from the NIH Guide for Grants and Contracts

Notice NOT-NS-21-075 from the NIH Guide for Grants and Contracts

Notice NOT-GM-21-052 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-RM-21-023 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the NIH Common Fund Bridge2AI Program which seeks to generate flagship data sets and best practices for the collection and preparation of AI/ML-ready data to address biomedical and behavioral research grand challenges. The purpose of this FOA is to support an integration, dissemination and evaluation center which will integrate activities across Bridge2AI Data Generation Projects to develop cross-cutting products and best-practices. This FOA invites cooperative agreement applications to develop a BRIDGE Center that will be responsible for integrating activities and knowledge across Data Generation Projects, disseminating products, best-practices, and skill development materials/activities, and evaluating all aspects of the Bridge2AI program with input from external stakeholder communities. The BRIDGE Center will combine cores of expertise in administration, team science, ethics, standards, tools optimization, and skills and workforce development.

Funding Opportunity RFA-NS-21-027 from the NIH Guide for Grants and Contracts. Reissue of RFA-NS-18-019: Understanding the dynamic activity of neural circuits is central to the NIH BRAIN Initiative. The invention, proof-of-concept investigation, and optimization of new technologies through iterative feedback from end users are key components of the BRAIN Initiative. This FOA seeks applications to optimize existing or emerging technologies through iterative testing with end users. The technologies and approaches should have potential to address major challenges associated with recording and modulation (including various modalities for stimulation/activation, inhibition and manipulation) of cells (i.e., neuronal and non-neuronal) and networks to enable transformative understanding of dynamic signaling in the central nervous system (CNS). These technologies and approaches should have previously demonstrated their transformative potential through initial proof-of-concept testing and are now ready for accelerated refinement. In conjunction, the manufacturing techniques should be scalable towards sustainable, broad dissemination and user-friendly incorporation into regular neuroscience research. Proposed technologies should be compatible with experiments in behaving animals, validated under in vivo experimental conditions, and capable of reducing major barriers to conducting neurobiological experiments and making new discoveries about the CNS. Technologies may engage diverse types of signaling beyond neuronal electrical activity such as optical, electrical, magnetic, acoustic or genetic recording/manipulation. Applications that seek to integrate multiple approaches are encouraged. If suitable, applications are expected to integrate appropriate domains of expertise, including biological, chemical and physical sciences, engineering, computational modeling and statistical analysis.

Funding Opportunity RFA-NS-21-026 from the NIH Guide for Grants and Contracts. Reissue of RFA-NS-18-020: Understanding the dynamic activity of brain circuits is central to the NIH BRAIN Initiative. This FOA seeks applications for proof-of-concept testing and development of new technologies and novel approaches for recording and modulation (including various modalities for stimulation/activation, inhibition and manipulation) of cells (i.e., neuronal and non-neuronal) and networks to enable transformative understanding of dynamic signaling in the central nervous system (CNS). This FOA seeks exceptionally creative approaches to address major challenges associated with recording and modulating CNS activity, at or near cellular resolution, at multiple spatial and/or temporal scales, in any region and throughout the entire depth of the brain. It is expected that the proposed research may be high-risk, but if successful, could profoundly change the course of neuroscience research. Proposed technologies should be compatible with experiments in behaving animals, validated under in vivo experimental conditions, and capable of reducing major barriers to conducting neurobiological experiments and making new discoveries about the CNS. Technologies may engage diverse types of signaling beyond neuronal electrical activity such as optical, magnetic, acoustic and/or genetic recording/manipulation. Applications that seek to integrate multiple approaches are encouraged. If suitable, applications are expected to integrate appropriate domains of expertise, including biological, chemical and physical sciences, engineering, computational modeling and statistical analysis.

Funding Opportunity RFA-NS-21-029 from the NIH Guide for Grants and Contracts. Reissue of RFA-NS-21-016: The goal of this funding opportunity announcement (FOA) is to solicit Initial Analgesic Development R61 applications that propose 2-year exploratory/planning awards that are expected to enable a future application for RFA-NS-21-015 HEAL Initiative: Team Research - for Initial Translational Efforts in Non-addictive Analgesic Development [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed). Thus, the limited scope of aims and approach of these applications are expected to establish a strong research team, feasibility, validity, or other technically qualifying results that support, enable, and/or lay the groundwork for a subsequent Team Research U19 application. These R61 awards will support the building of a research team to collect initial data and recruit additional collaborators. The proposal must include a plan for developing a strong research team, as well as a strategy to collect preliminary data linking putative therapeutic targets to the proposed pain indication and supporting the hypothesis that altering target activity will produce desirable outcomes for the disease.

Notice NOT-HD-21-036 from the NIH Guide for Grants and Contracts

Notice NOT-NR-21-004 from the NIH Guide for Grants and Contracts

Notice NOT-ES-21-008 from the NIH Guide for Grants and Contracts

Notice NOT-NS-21-072 from the NIH Guide for Grants and Contracts

D. E. Shaw Research is seeking computational chemists and biologists, as well as other computational scientists with a track record of achievement, to join our

Funding Opportunity PAR-21-138 from the NIH Guide for Grants and Contracts. The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providing such an opportunity for longer term support to ESIs, the NCI intends to offer flexibility and opportunity for creativity and innovation and additional time to successfully launch their careers and to become more established before having to submit renewal applications (NOT-CA-18-037). The objective of the NCI's ESI MERIT Award is to allow eligible investigators the opportunity to obtain up to 7 years of support in two segments:

£52000 - £65000 + excellent career potential + flexible / home working + full autonomy: YOH: Yoh Scientific are working with a company developing bespoke biomarker tests to identify patients and show treatment efficacy for novel therapeutic... London (Greater) (GB)

£52000 - £65000 + excellent career potential + flexible / home working + full autonomy: YOH: Yoh Scientific are working with a company developing bespoke biomarker tests to identify patients and show treatment efficacy for novel therapeutics. London (Greater) (GB)

Expertise in bioinformatic approaches for analysis of large data sets. Mastery of techniques used for nucleic acid and protein manipulation and analysis.
From Illumina - Sat, 05 Jun 2021 00:11:05 GMT - View all Madison, WI jobs

5.Nimbly adapts bioinformatics tools, visualization packages, and annotation resources to perform accurate research analysis – flexibility and competency in…
From Medical College of Wisconsin - Fri, 04 Jun 2021 21:09:09 GMT - View all Milwaukee, WI jobs

Notice NOT-OD-21-138 from the NIH Guide for Grants and Contracts